Clinical relevance of prostate cancer genetic characterization: literature review
- Authors: Tolkach Y.1,2, Reva S.3,4, Nosov A.3,4, Imkamp F.1,2, Van Poppel H.5,6
-
Affiliations:
- Hannover Medical School, Urology and Urologic Oncology Clinic, Hannover, Germany
- Carl-Neuberg-Str. 1, 30625 Hannover, Germany
- Department of Oncourology FSBI “N.N. Petrov Cancer Research Institute” of thу Ministry of Health of Russia
- 68, Leningradskaya St., village Pesochny, Saint-Petersburg 197758, Russia
- Department of Urology, University Hospitals of Catholic University of Leuven, Leuven, Belgium
- UZ Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
- Issue: Vol 11, No 2 (2015)
- Pages: 99-106
- Section: PROSTATE CANCER
- Published: 30.06.2015
- URL: https://oncourology.abvpress.ru/oncur/article/view/461
- DOI: https://doi.org/10.17650/1726-9776-2015-11-2-99-106
- ID: 461
Cite item
Full Text
Abstract
Molecular and genetic characterization of the prostate cancer seems to be a very relevant issue for clinical practice with regard to diagnostics, prognosis, treatment selection and assessment of therapy efficacy. A lot of fundamental studies assault the genetic basis of the disease and the differences in the phenotypic traits of prostate tumors. However, the significant gap is seen between the huge amount of studies to genetic characterization of prostate cancer, which often have a limited way to translation into the clinical practice or simply were not conceived to be so, and clinical practice. Substantial difficulties on the way are multifocality of the prostate carcinoma, inter- and intrafocal heterogeneity and abundance of recurrent genetic alterations, the role of which is understudied to date. In this review we have aimed at the providing an overview of the current studies, being the most close to translation in clinical practice. The common applications and problems are discussed.
About the authors
Yu. Tolkach
Hannover Medical School, Urology and Urologic Oncology Clinic, Hannover, Germany; Carl-Neuberg-Str. 1, 30625 Hannover, Germany
Author for correspondence.
Email: yuri.tolkach@gmail.com
Russian Federation
S. Reva
Department of Oncourology FSBI “N.N. Petrov Cancer Research Institute” of thу Ministry of Health of Russia; 68, Leningradskaya St., village Pesochny, Saint-Petersburg 197758, Russia
Email: sgreva79@mail.ru
Russian Federation
A. Nosov
Department of Oncourology FSBI “N.N. Petrov Cancer Research Institute” of thу Ministry of Health of Russia; 68, Leningradskaya St., village Pesochny, Saint-Petersburg 197758, RussiaRussian Federation
F. Imkamp
Hannover Medical School, Urology and Urologic Oncology Clinic, Hannover, Germany; Carl-Neuberg-Str. 1, 30625 Hannover, GermanyRussian Federation
H. Van Poppel
Department of Urology, University Hospitals of Catholic University of Leuven, Leuven, Belgium; UZ Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, BelgiumRussian Federation
References
Supplementary files

